AU2011323371A1 - Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate - Google Patents
Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate Download PDFInfo
- Publication number
- AU2011323371A1 AU2011323371A1 AU2011323371A AU2011323371A AU2011323371A1 AU 2011323371 A1 AU2011323371 A1 AU 2011323371A1 AU 2011323371 A AU2011323371 A AU 2011323371A AU 2011323371 A AU2011323371 A AU 2011323371A AU 2011323371 A1 AU2011323371 A1 AU 2011323371A1
- Authority
- AU
- Australia
- Prior art keywords
- methyl
- pyrrolo
- carboxamido
- piperidine
- pyrimidin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41060210P | 2010-11-05 | 2010-11-05 | |
| US61/410,602 | 2010-11-05 | ||
| PCT/US2011/059086 WO2012061565A1 (en) | 2010-11-05 | 2011-11-03 | Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2011323371A1 true AU2011323371A1 (en) | 2013-05-23 |
Family
ID=45002136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2011323371A Abandoned AU2011323371A1 (en) | 2010-11-05 | 2011-11-03 | Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate |
Country Status (16)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015150337A1 (en) | 2014-04-01 | 2015-10-08 | Amakem Nv | Lim kinase inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI439457B (zh) * | 2007-09-28 | 2014-06-01 | Lexicon Pharmaceuticals Inc | (s)-2-胺基-3-(4-(2-胺基-6-((r)-1-(4-氯-2-(3-甲基-1h-吡唑-1-基)苯基)-2,2,2-三氟乙氧)-嘧啶-4-基)苯基)丙酸乙酯之固體形式與其使用方法 |
| EP2297153B1 (en) * | 2008-04-21 | 2015-05-27 | Lexicon Pharmaceuticals, Inc. | Limk2 inhibitors, compositions comprising them, and methods of their use |
-
2011
- 2011-11-01 TW TW100139812A patent/TW201302754A/zh unknown
- 2011-11-03 JP JP2013537811A patent/JP2013541588A/ja active Pending
- 2011-11-03 CN CN2011800533551A patent/CN103298815A/zh active Pending
- 2011-11-03 AU AU2011323371A patent/AU2011323371A1/en not_active Abandoned
- 2011-11-03 BR BR112013011094A patent/BR112013011094A2/pt not_active IP Right Cessation
- 2011-11-03 WO PCT/US2011/059086 patent/WO2012061565A1/en not_active Ceased
- 2011-11-03 KR KR1020137014386A patent/KR20140003433A/ko not_active Withdrawn
- 2011-11-03 MX MX2013004923A patent/MX2013004923A/es not_active Application Discontinuation
- 2011-11-03 EP EP11785536.1A patent/EP2635584A1/en not_active Withdrawn
- 2011-11-03 US US13/288,321 patent/US8735408B2/en active Active
- 2011-11-03 RU RU2013125755/04A patent/RU2013125755A/ru not_active Application Discontinuation
- 2011-11-03 CA CA2817112A patent/CA2817112A1/en not_active Abandoned
- 2011-11-03 SG SG2013033618A patent/SG190098A1/en unknown
- 2011-11-04 AR ARP110104111A patent/AR083756A1/es unknown
-
2013
- 2013-04-22 IL IL225884A patent/IL225884A0/en unknown
- 2013-04-24 ZA ZA2013/02996A patent/ZA201302996B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2013125755A (ru) | 2014-12-10 |
| CA2817112A1 (en) | 2011-11-05 |
| TW201302754A (zh) | 2013-01-16 |
| JP2013541588A (ja) | 2013-11-14 |
| WO2012061565A1 (en) | 2012-05-10 |
| ZA201302996B (en) | 2014-06-25 |
| US20120122898A1 (en) | 2012-05-17 |
| CN103298815A (zh) | 2013-09-11 |
| BR112013011094A2 (pt) | 2016-08-23 |
| SG190098A1 (en) | 2013-06-28 |
| IL225884A0 (en) | 2013-07-31 |
| AR083756A1 (es) | 2013-03-20 |
| EP2635584A1 (en) | 2013-09-11 |
| MX2013004923A (es) | 2013-06-28 |
| KR20140003433A (ko) | 2014-01-09 |
| US8735408B2 (en) | 2014-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2821102C (en) | Crystalline forms of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4-[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2,4-diamine | |
| CA2669736C (en) | Heterocyclic compounds as tyrosine kinase modulators | |
| CA3214095A1 (en) | Lactams as cbl-b inhibitors | |
| JP2000506847A (ja) | 4―アミノ―ピリミジン誘導体、これらの化合物を含む医薬品、それらの使用及び製造法 | |
| CN111989099A (zh) | 作为cdk4和cdk6抑制剂的2h-吲唑衍生物及其治疗用途 | |
| KR20130028045A (ko) | 3-(2,6―디클로로―3,5―디메톡시―페닐)-1-{6-[4-(4-에틸-피페라진-1-일)-페닐아미노]-피리미딘-4-일}-1-메틸-우레아의 결정질 형태 및 그의 염 | |
| JP2018502882A (ja) | 2−(5−(3−フルオロフェニル)−3−ヒドロキシピコリンアミド)酢酸の固体形態、その組成物及び使用 | |
| TWI839131B (zh) | 共晶體、其藥物組合物以及涉及其的治療方法 | |
| RU2613555C2 (ru) | Моногидратный кристалл калиевой соли фимасартана, способ его получения и содержащая его фармакологическая композиция | |
| AU1347201A (en) | 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline nmda/nr2b antagonists | |
| KR20240155293A (ko) | 고체 형태의 (s)-1-((2',6-비스(디플루오로메틸)-[2,4'-바이피리딘]-5-일)옥시)-2,4-디메틸펜탄-2-아민 및 이의 염 | |
| AU2011323302A1 (en) | Crystalline forms of ( S ) - 2 - amino - 3 - (4 - ( 2 - amino - 6 - ( (R) - 1 - (4 - ch loro-2- (3 -methyl- 1H- pyrazol- 1 -yl) phenyl) - 2, 2, 2 - trifluoroethoxy) pyrimidin- 4 - yl) phenyl) propanoic acid | |
| EP2740458B1 (en) | Packaging comprising forms of sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide | |
| US8735408B2 (en) | Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate | |
| CN103562183B (zh) | 奥米沙班的苯甲酸盐 | |
| KR20250149691A (ko) | 항섬유화 화합물의 고체 형태, 염 및 다형체 | |
| HK1183667A (en) | Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate | |
| CN106854164A (zh) | 沙库比曲氨丁三醇盐的一种新晶型及其制备方法和用途 | |
| WO2011149010A1 (ja) | 新規インダゾール誘導体またはその塩およびその製造中間体、ならびに、それを用いた網脈絡膜変性疾患の予防または治療剤、網脈絡膜変性疾患の治療方法、インダゾール誘導体またはその塩の使用 | |
| WO2013130600A1 (en) | Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith | |
| HK1189584B (en) | Benzoic acid salt of otamixaban |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |